These findings support the notion that the inhibitory action of nuclear DUSP1 on specific MAPKs at specific time-points could be a determinant of the survival of NB cells challenged with pro-apoptotic or pro-differentiation chemotherapies. Here, DUSP1 is linked to neuroblastoma.